SAR402671, GZ402671 or GZ / SAR402671 ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
19	Lysosomal storage disease	2

19. Lysosomal storage disease

Clinical trials : 899 / Drugs : 684 - (DrugBank : 99) / Drug target genes : 51 - Drug target pathways : 182

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-005402-10-DE (EUCTR)	23/03/2022	05/01/2022	Study to evaluate the efficacy and safety of venglustat in adult and pediatric patients with Gaucher ...	A phase 3, multicenter, multinational, randomized, double-blind, double-dummy, active-comparator stu ...	Gaucher's disease type III MedDRA version: 24.1;Level: PT;Classification code 10075699;Term: Gaucher ...	Product Name: venglustat Product Code: SAR402671, GZ402671 or GZ / SAR402671 INN or Proposed INN: Veng ...	Sanofi-aventis recherche & développement	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	2	Phase 3	Brazil;Germany;China;United States;Taiwan;Turkey;United Kingdom;Egypt;France;Hungary;Canada;Argentin ...
2	EUCTR2021-005402-10-FR (EUCTR)		27/01/2022	Study to evaluate the efficacy and safety of venglustat in adult and pediatric patients with Gaucher ...	A phase 3, multicenter, multinational, randomized, double-blind, double-dummy, active-comparator stu ...	Gaucher's disease type III MedDRA version: 24.1;Level: PT;Classification code 10075699;Term: Gaucher ...	Product Name: venglustat Product Code: SAR402671, GZ402671 or GZ / SAR402671 INN or Proposed INN: Veng ...	Sanofi-aventis recherche & développement	NULL	NA			Female: yes Male: yes	50	Phase 3	United States;Taiwan;Turkey;United Kingdom;France;Egypt;Hungary;Canada;Argentina;Brazil;Germany;Chin ...

First Previous1Next Last